Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

CUSIP: 055477103

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
63,302,078
Total 13F shares
46,709,070
Share change
+5,394,878
Total reported value
$813,618,424
Price per share
$17.42
Number of holders
84
Value change
+$73,899,338
Number of buys
54
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 055477103?
CUSIP 055477103 identifies BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) as of Q4 2024

As of 31 Dec 2024, Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,709,070 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Red Tree Management, LLC, TPG GP A, LLC, Omega Fund Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, BRAIDWELL LP, Deep Track Capital, LP, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 84 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.